Cinacalcet: the chemical parathyroidectomy?
作者信息
Bellasi Antonio, Cozzolino Mario
机构信息
Renal Division, Department of Health Sciences , San Paolo Hospital, University of Milan , Milan , Italy ; Department of Nephrology , Ospedale Sant'Anna , Como , Italy.
Renal Division, Department of Health Sciences , San Paolo Hospital, University of Milan , Milan , Italy.
出版信息
Clin Kidney J. 2013 Jun;6(3):253-6. doi: 10.1093/ckj/sft036.
Abstract
摘要
相似文献
1
Cinacalcet: the chemical parathyroidectomy?西那卡塞：化学性甲状旁腺切除术？
Clin Kidney J. 2013 Jun;6(3):253-6. doi: 10.1093/ckj/sft036.
2
Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl.一名青少年甲状旁腺切除术后持续性高钙血症及盐酸西那卡塞治疗效果
Clin Chem. 2006 Dec;52(12):2286-93. doi: 10.1373/clinchem.2006.070219. Epub 2006 Nov 14.
3
Acute and one-year effects of cinacalcet in patients with persistent primary hyperparathyroidism after unsuccessful parathyroidectomy.西那卡塞对甲状旁腺切除术后持续性原发性甲状旁腺功能亢进患者的急性及一年期影响。
Am J Med Sci. 2008 Feb;335(2):111-4. doi: 10.1097/MAJ.0b013e3181379f3e.
4
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.盐酸西那卡塞：一种治疗慢性肾脏病所致继发性甲状旁腺功能亢进的新疗法。
J Ren Nutr. 2006 Jul;16(3):253-8. doi: 10.1053/j.jrn.2006.04.010.
5
Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis.甲状旁腺切除术与西那卡塞治疗三发性甲状旁腺功能亢进的回顾性分析
Langenbecks Arch Surg. 2019 Feb;404(1):71-79. doi: 10.1007/s00423-019-01755-4. Epub 2019 Feb 7.
6
Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients.移植前西那卡塞对肾移植受者矿物质代谢的影响。
Nephrology (Carlton). 2016 Jan;21(1):46-54. doi: 10.1111/nep.12536.
7
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.使用拟钙剂盐酸西那卡塞对继发性甲状旁腺功能亢进进行长期治疗。
Nephrol Dial Transplant. 2005 Oct;20(10):2186-93. doi: 10.1093/ndt/gfh966. Epub 2005 Jul 19.
8
Outcomes in patients with renal hyperparathyroidism requiring cinacalcet pre-operatively followed by parathyroidectomy.术前应用西那卡塞治疗后行甲状旁腺切除术的甲状旁腺功能亢进症患者的结局。
Am J Surg. 2019 Jan;217(1):146-151. doi: 10.1016/j.amjsurg.2018.06.016. Epub 2018 Jun 19.
9
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.拟钙剂盐酸西那卡塞对继发性甲状旁腺功能亢进患者心血管疾病、骨折及健康相关生活质量的影响。
Kidney Int. 2005 Oct;68(4):1793-800. doi: 10.1111/j.1523-1755.2005.00596.x.
10
Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.西那卡塞与甲状旁腺切除术治疗肾移植术后继发性甲状旁腺功能亢进的比较
Rom J Intern Med. 2016 Sep 1;54(3):184-189. doi: 10.1515/rjim-2016-0027.
引用本文的文献
1
New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology.继发性甲状旁腺功能亢进的新情况：依特卡塞。意大利肾脏病学会 CKD-MBD 工作组立场文件。
J Nephrol. 2020 Apr;33(2):211-221. doi: 10.1007/s40620-019-00677-0. Epub 2019 Dec 18.
2
Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.继发性甲状旁腺功能亢进的治疗：依特卡肽的临床应用价值
Ther Clin Risk Manag. 2017 Jun 1;13:679-689. doi: 10.2147/TCRM.S108490. eCollection 2017.
本文引用的文献
1
Vitamin D: something new under the sun.维生素D：阳光下的新事物。
Clin Kidney J. 2012 Aug;5(4):285-7. doi: 10.1093/ckj/sfs080.
2
Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction.接受西那卡塞治疗继发性甲状旁腺功能亢进的透析患者血清磷降低主要源于甲状旁腺激素降低。
Clin Kidney J. 2013 Jun;6(3):287-294. doi: 10.1093/ckj/sft026. Epub 2013 Apr 11.
3
Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.在血液透析患者中，使用拟钙剂治疗继发性甲状旁腺功能亢进症时甲状旁腺激素和血清磷的降低之间的关系。
Nephron Clin Pract. 2012;121(3-4):c124-30. doi: 10.1159/000345164. Epub 2012 Nov 29.
4
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.西那卡塞对透析患者心血管疾病的影响。
N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.
5
Effects of phosphate binders in moderate CKD.中重度 CKD 患者的磷酸盐结合剂治疗效果。
J Am Soc Nephrol. 2012 Aug;23(8):1407-15. doi: 10.1681/ASN.2012030223. Epub 2012 Jul 19.
6
Improved long-term survival of dialysis patients after near-total parathyroidectomy.甲状旁腺全切除加前臂移植术后透析患者的长期生存率提高。
J Am Coll Surg. 2012 Apr;214(4):400-7; discussion 407-8. doi: 10.1016/j.jamcollsurg.2011.12.046.
7
PTH--a particularly tricky hormone: why measure it at all in kidney patients?甲状旁腺激素——一种特别棘手的激素：为什么要在肾病患者身上检测它？
Clin J Am Soc Nephrol. 2013 Feb;8(2):299-312. doi: 10.2215/CJN.09580911. Epub 2012 Mar 8.
8
Differences in bone quality in low- and high-turnover renal osteodystrophy.低转换型和高转换型肾性骨营养不良症的骨质量差异。
J Am Soc Nephrol. 2012 Mar;23(3):525-32. doi: 10.1681/ASN.2010121253. Epub 2011 Dec 22.
9
Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.新千年第一个十年的肾性骨营养不良：对黑人和白人患者 630 例骨活检的分析。
J Bone Miner Res. 2011 Jun;26(6):1368-76. doi: 10.1002/jbmr.309.
10
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.ADVANCE 研究：一项随机研究，评估西那卡塞联合小剂量维生素 D 对血液透析患者血管钙化的影响。
Nephrol Dial Transplant. 2011 Apr;26(4):1327-39. doi: 10.1093/ndt/gfq725. Epub 2010 Dec 8.
Zotero 插件